Showing 7091-7100 of 10619 results for "".
- Systematic Review Examines Hematoma Reduction Techniques in Faceliftshttps://reachmd.com/news/systematic-review-examines-hematoma-reduction-techniques-in-facelifts/2484473/A new systematic review and meta-analysis published in Facial Plastic Surgery & Aesthetic Medicine underscores the incidence of hematoma after rhytidectomy and evaluates commonly used adjunctive techniques aimed at reducing this complication. The analysis focused on patients undergoi
- Pancreatic Duct Dilation: A Sentinel Biomarker for Early Interventionhttps://reachmd.com/news/pancreatic-duct-dilation-a-sentinel-biomarker-for-early-intervention/2484443/Johns Hopkins investigators have shown that mild main pancreatic duct dilation identifies higher pancreatic cancer risk in high‑risk surveillance cohorts. In a lo
- Detalimogene: A Promising Bladder-Sparing Therapy in NMIBChttps://reachmd.com/news/detalimogene-a-promising-bladder-sparing-therapy-in-nmibc/2484408/The LEGEND trial reports a 62% complete response rate at 6 months for detalimogene in BCG‑unresponsive non‑muscle
- AAFPRS Forecasts Regeneration, Precision, and Personalization as Defining Aesthetic Trends for 2026https://reachmd.com/news/aafprs-forecasts-regeneration-precision-and-personalization-as-defining-aesthetic-trends-for-2026/2484425/Aesthetic medicine is rapidly evolving beyond enhancement and rejuvenation, moving toward regenerative, precision-driven care tailored to the individual. The American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) has released its annual aesthetic trend forecast, highlighting the t
- Exploring Calcitonin-Negative Medullary Thyroid Carcinoma: Origins, Diagnostics, and Managementhttps://reachmd.com/news/exploring-calcitonin-negative-medullary-thyroid-carcinoma-origins-diagnostics-and-management/2484388/Calcitonin-negative medullary thyroid carcinoma (MTC) complicates routine endocrine oncology workflows by lacking the hallmark biochemical signal that normally triggers investigation and surveillance. This atypical absence can undermine standard screening and delay recognition of clinically
- Evaluating Liver Hypertrophy Techniques: LVD vs. vALPPS in Staged Hepatectomyhttps://reachmd.com/news/evaluating-liver-hypertrophy-techniques-lvd-vs-valpps-in-staged-hepatectomy/2484356/New comparative data in patients with a small future liver remnant (FLR) undergoing staged hepatectomy contrast Liver Venous Deprivation (LVD) and vA
- Continuous Norepinephrine Infusion: A Shift in Perioperative Hemodynamicshttps://reachmd.com/news/continuous-norepinephrine-infusion-a-shift-in-perioperative-hemodynamics/2484367/A randomized trial in a high‑risk noncardiac surgical cohort found that continuous norepinephrine infusion during anesthesia induction provided superior hemodynamic control versus manual bolus
- Evaluation of First-Line Intensification in EGFR-Mutant NSCLChttps://reachmd.com/news/evaluation-of-first-line-intensification-in-egfr-mutant-nsclc/2484335/FLAURA2 and MARIPOSA demonstrate that first-line intensification with osimertinib-based combinations significantly prolongs overall survival in NSCLC
- Flexible Percutaneous Laser Lithotripsy: Evaluating Efficacy and Safety in Western Populationshttps://reachmd.com/news/flexible-percutaneous-laser-lithotripsy-evaluating-efficacy-and-safety-in-western-populations/2484315/Flexible percutaneous laser lithotripsy achieves high technical success for Western patients with intrahepatic stones, including those with surgicall
- Addressing the Menopause Care Gap: Key Findings on Barriers and Opportunitieshttps://reachmd.com/news/addressing-the-menopause-care-gap-key-findings-on-barriers-and-opportunities/2484288/A Mayo Clinic survey of nearly 5,000 women aged 45-60 in primary care found that 34% reported moderate‑to‑very‑severe menopause symptoms, yet most did not see